Penumbra (PEN) Selling, General & Administrative (2014 - 2026)
Penumbra (PEN) Selling, General & Administrative (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 2.96 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 522.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -207.22 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 349.70 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 351.80 Mn |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | 192.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 192.80 Mn |
| Dec 31, 2025 | 181.10 Mn |
| Sep 30, 2025 | 168.90 Mn |
| Jun 30, 2025 | 159.96 Mn |
| Mar 31, 2025 | 153.46 Mn |
| Dec 31, 2024 | 147.94 Mn |
| Sep 30, 2024 | 139.74 Mn |
| Jun 30, 2024 | 141.90 Mn |
| Mar 31, 2024 | 144.41 Mn |
| Dec 31, 2023 | 130.02 Mn |
| Sep 30, 2023 | 125.92 Mn |
| Jun 30, 2023 | 127.44 Mn |
| Mar 31, 2023 | 123.08 Mn |
| Dec 31, 2022 | 115.63 Mn |
| Sep 30, 2022 | 108.57 Mn |
| Jun 30, 2022 | 114.62 Mn |
| Mar 31, 2022 | 110.90 Mn |
| Dec 31, 2021 | 113.50 Mn |
| Sep 30, 2021 | 94.40 Mn |
| Jun 30, 2021 | 90.64 Mn |